Switch from dabrafenib/trametinib combination therapy to encorafenib/binimetinib combination therapy with transition of serum lactate dehydrogenase level in melanoma: A case report

Corresponding Author

Michihiro Kono M.D., Ph.D.

Department of Dermatology and Plastic Surgery, Akita University Graduate School of Medicine, Akita, Japan

Correspondence

Michihiro Kono, M.D., Ph.D., Department of Dermatology and Plastic Surgery, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan, Phone: +81-18-884-6153; Fax: +81-18-836-2618,

Email: miro@med.akita-u.ac.jp

Search for more papers by this author

留言 (0)

沒有登入
gif